CADASIL Data: Donepezil Had No Cognitive Benefit: The drug did improve executive function.

NEW ORLEANS — Donepezil had no effect on cognitive impairment in a recent study of patients with vascular dementia, but the acetylcholinesterase inhibitor was associated with significant improvement on several measures of executive function in the patients, Dr. Martin Dichgans reported at International Stroke Conference 2008.